The role and place of the health related quality of life in the modern management of lung cancer patients

Journal Title: OncoReview - Year 2011, Vol 1, Issue 4

Abstract

Quality of life is a personal perception of the individual position held in the life, within the context of culture and value system and in relation to their objectives, expectations and worries. Patients perceptions of quality of life is changing during the treatment, taking into account the aspect of the disease. Diagnostic capabilities and the results of oncological treatment have been improving, consequently the health-related quality of life becomes more and more important. Surgical methods in lung cancer patients are associated with decreased of quality of life, particularly in the perioperative period and shortly after surgery. The addition of chemotherapy or radiation after surgery therapy does not reduce the quality of life of these patients. The main aim of chemotherapy is a reduction or relief of symptoms associated with cancer, obtaining objective response, prolonged survival, as well as improving the quality of life. Lung cancer patients assess their quality of life lower than healthy individuals. Multidrug chemotherapy based on platinum, as well as new targeted molecular methods, improve the general quality of life, but in this area prospective and randomized trials, take account not only aspects of the objective, but subjective illness as well. Research on subjective aspects of the disease are becoming more and more interesting, and initial studies suggest that temperament traits and selected strategies for coping with the disease might be related, and even influence the therapeutic process, as well as be predictors of treatment outcome, no doubt enhancing the health-relatedquality of life.

Authors and Affiliations

Anna Kieszkowska-Grudny

Keywords

Related Articles

Ewerolimus w codziennej praktyce klinicznej. Omówienie niemieckiego nieinterwencyjnego badania ewerolimusu w terapii przerzutowego raka nerki po niepowodzeniu leczenia inhibitorami kinaz tyrozynowych

Leczenie przerzutowego raka nerki ewerolimusem po niepowodzeniu terapii anty-VEGF jest obecnie standardem. Badacze niemieccy zebrali dane z 79 ośrodków w celu oceny bezpieczeństwa i skuteczności leku. Otrzymane wyniki by...

Improving cancer outcomes through better cancer data in Poland

Based on NFZ published aggregate data, the public spending on cancer care in Poland was 6.3 billion PLN in 2011 (or approximately 10% of total public health spending). Poland is one of the few large countries in the worl...

Recommendations for diagnostics and therapy of gastrointestinal stromal tumors (GIST) in 2010

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of gastrointestinal tract. Advances in the understanding of the molecular mechanisms of GIST pathogenesis have resulted for last years in the...

Therapeutic rehabilitation of cancer patients. Why and what for?

Types of oncological rehabilitation and its objectives are described. It includes information on many manifestations of oncological diseases that an internist has to deal with, which are conditioned not only by the oncol...

Everolimus in every day practice of metastatic renal cell carcinoma therapy – one center experience

Introduction: Everolimus is a selective mTOR inhibitor which received approval for treatment of advanced renal cell carcinoma (mRCC) after progression on or after treatment with VEGF-targeted therapy. The aim of this stu...

Download PDF file
  • EP ID EP53119
  • DOI -
  • Views 217
  • Downloads 0

How To Cite

Anna Kieszkowska-Grudny (2011). The role and place of the health related quality of life in the modern management of lung cancer patients. OncoReview, 1(4), -. https://europub.co.uk./articles/-A-53119